Clinical Trial Update: Botulinum Toxin A for Treatment of Catocholamine Induced Finger Necrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating botulinum toxin A for the treatment of catecholamine-induced finger necrosis, sponsored by Sheba Medical Center; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catecholamine-induced Finger Necrosis

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Sheba Medical Center | Conditions: Catocholamine Induced Finger Necrosis | Phase 4 | Status: UNKNOWN